Title:
【発明の名称】治療における腫瘍壊死因子アルファおよび血管内皮成長因子の抑制
Document Type and Number:
Japanese Patent JP2001525816
Kind Code:
A
Abstract:
Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed are compositions comprising a TNF alpha antagonist and a VEGF antagonist. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
Inventors:
Mark Feldman
Maini, Labinder, Eggplant
Paleolog, Eve, Maria
Maini, Labinder, Eggplant
Paleolog, Eve, Maria
Application Number:
JP54891198A
Publication Date:
December 11, 2001
Filing Date:
May 12, 1998
Export Citation:
Assignee:
The Kennedy Institute of Rheumatology
International Classes:
A61K45/06; A61K31/00; A61K31/454; A61K31/505; A61K38/00; A61K39/395; A61P29/00; A61P37/00; A61P37/02; A61P43/00; C07K16/24; (IPC1-7): A61K45/06; A61K31/454; A61K38/00; A61K39/395; A61P29/00; A61P37/02; A61P43/00
Attorney, Agent or Firm:
Yoshinori Hosoda